Neogenin Regulation of BMP-Induced Canonical Smad Signaling and Endochondral Bone Formation  by Zhou, Zheng et al.
Developmental Cell
ArticleNeogenin Regulation of BMP-Induced Canonical
Smad Signaling and Endochondral Bone Formation
Zheng Zhou,1 Jianxin Xie,1 Daehoon Lee,1 Yu Liu,1 Jiung Jung,1 Lijuan Zhou,1 Shan Xiong,1 Lin Mei,1
and Wen-Cheng Xiong1,*
1Institute of Molecular Medicine and Genetics and Department of Neurology, Medical College of Georgia, Augusta, GA 30912, USA
*Correspondence: wxiong@mcg.edu
DOI 10.1016/j.devcel.2010.06.016SUMMARY
Neogenin has been identified as a receptor for the
neuronal axon guidance cues netrins and RGMs
(repulsive guidance molecules). Here we provide
evidence for neogenin in regulating endochondral
bone development and BMP (bone morphogenetic
protein) signaling. Neogenin-deficient mice were
impaired in digit/limb development and endochon-
dral ossification. BMP2 induction of Smad1/5/8
phosphorylation and Runx2 expression, but not non-
canonical p38 MAPK activation, was reduced in
chondrocytes from neogenin mutant mice. BMP
receptor association with membrane microdomains,
which is necessary for BMP signaling to Smad, but
not p38MAPK, was diminished in neogenin-deficient
chondrocytes. Furthermore, RGMs appear to
mediate neogenin interaction with BMP receptors
in chondrocytes. Taken together, our results indicate
that neogenin promotes chondrogenesis in vitro and
in vivo, revealing an unexpected mechanism under-
lying neogenin regulation of BMP signaling.
INTRODUCTION
Endochondral ossification is a cellular process essential for the
formation of long bones andmost craniofacial bones during skel-
etal development (Erlebacher et al., 1995; Pogue and Lyons,
2006). It begins with a cartilage template consisting of
condensed mesenchymal cells that undergo sequential chon-
drocyte proliferation and maturation (Erlebacher et al., 1995;
Mackie et al., 2008; Pogue and Lyons, 2006). Differentiated
chondrocytes eventually ossify to form bone. This process is
regulated by many global hormones including growth hormones
and thyroids as well as local growth factors such as BMP, FGF
(fibroblastic growth factor), PTHrP (parathyroid hormone related
protein), and Ihh (Indian hedgehog) (Kronenberg, 2003). Among
them, BMPs, members of transforming growth factor b (TGFß)
superfamily, are considered as master regulators of both chon-
drogenesis and osteoblastogenesis. Multiple BMPs (BMP2/4/6)
and their receptors type IA, IB, and II are expressed by chondro-
cytes and periochondrium (Pathi et al., 1999; Yoon et al.,
2005). Their mutation results in aberrant chondrogenesis in
mice (Yoon and Lyons, 2004; Yoon et al., 2005, 2006). Upon90 Developmental Cell 19, 90–102, July 20, 2010 ª2010 Elsevier Inc.BMP stimulation, type I and II receptors form heterodimers to
recruit and phosphorylate R-Smads including Smad1, Smad5,
and Smad8. R-Smads subsequently form a complex with
common Smads (Smad4) and translocate into nuclei to activate
transcription of target genes such as Runx2 (ten Dijke, 2006;
Wotton and Massague, 2001; Zou et al., 1997). In addition,
non-Smad (noncanonical) BMP signaling mediated by
Tak1/Tab1 activates p38 MAPK (Gilboa et al., 2000; Hassel
et al., 2003; Nohe et al., 2002).
Neogenin, a member of the DCC (deleted in colorectal cancer)
family, regulates neuronal axon guidance by serving as
a receptor for the guidance cue netrin (Keino-Masu et al.,
1996) as well as repulsive cue RGMs (Cole et al., 2007;
Rajagopalan et al., 2004). In addition to the nervous system, neo-
genin is also expressed at high levels in cartilages during embry-
onic development (Gad et al., 1997). However, its role in cartilage
or bone development remains largely unknown. In this study, we
provide evidence for a role of neogenin in chondrogenesis.
Neogenin mutant mice showed digit maldevelopment and
defective endochondral ossification or bone formation.
Chondrocytes from neogenin mutant mice exhibited impaired
differentiation. We have investigated mechanisms by which neo-
genin regulates endochondroal bone formation. Our results
demonstrate an unexpected mechanism by which neogenin
regulates BMP signaling and function in terminal chondrogene-
sis and skeletal development.RESULTS
Neogenin Expression in Growth Plates and Bone Cells
To study neogenin’s in vivo function, we took advantage of neo-
genin-deficient mice generated by retrotransposon-mediated
‘‘gene trapping’’ (Mitchell et al., 2001). The insertion of the retro-
transposon into the intron between exons 7 and 8 in the neogenin
gene resulted in90% reduction in neogenin protein in homozy-
gotes (neogeninm/m) (see Figure S1A available online). The
mutant mice in C57/BL6 background reduced in body size and
weight (Figure S1B andS1C) and died30 days after birth, impli-
cating neogenin in skeletal development. To test this hypothesis,
mutant embryos were stained with Alcian blue (for chondrocyte
matrix) and alizarin red (for mineralization). The skeleton size of
E14.5 embryos was reduced (Figure S1D). At this age, minerali-
zation of digits of phalanges and sternum was readily detectable
in control; however, it was drastically reduced or barely detect-
able in mutant embryos (Figure S1D). These results indicate
defective digit development in neogeninm/m embryos.
Figure 1. Neogenin Expression in P1 Growth Plates and Impaired Endochondral Bone Formation in Neogenin-Deficient Mice
(A) Illustration of endochondral ossification displayed layered structure.
(B) Immunohistochemical staining analysis of neogenin distribution in cartilage. The radius sections of newborn wild-typemice were incubatedwith anti-neogenin
or nonspecific IgG antibodies and visualized by DAB. Bar, 120 mm.
(C) Western blot analysis of lysates from wild-type and neogenin mutant chondrocytes using indicated antibodies.
(D) Lac Z activity in cartilage of neogeninm\m and +/m mice, in comparison with immunohistochemical staining analysis of neogenin. The growth plates of distal
ulnas from new bore mice with indicated genotype were examined. Each layer structures were indicated. Neogenin was highly expressed in hypertrophic chon-
drocytes and osteoblasts of the trabecular bone. Bar, 10 mm.
(E–G) Chondrogenesis and bone development examined by hematoxylin/eosin and Alcian blue/von Kossa staining in ulna sections of wild-type and neogenin
mutant littermates at age of P1. Higher power images of each layer were shown in (G). Note that increased pre- and hypertrophic chondrocyte zones, reduced
bone matrix and mineralization (E, star), and decreased trabecular bone volume (G, arrow) were demonstrated. The bone collar formation was not affected
(E, asterisk). Quantitative analysis of bone lengths was shown in (F). The length of pre- and hypertrophic zone over total was significantly increased in mutant
growth plates (*p < 0.05, significant difference from wild-type control).
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examined its expression in ulna growth plates, where chondro-
genesis and endochondrial bone formation occurs (Pogue and
Lyons, 2006). Chondrocytes of different stages (resting, prolifer-
ative, prehypertrophic, and hypertrophic) are distributed in
distinct zones in developing long-bone cartilages (Figure 1A)
(Goldring et al., 2006; Pogue and Lyons, 2006). Neogenin was
expressed in nearly all zones, but at higher levels in hypertrophic
chondrocytes and osteoblasts of trabecular bones (Figure 1B).
The staining of neogenin was specific because the antibody
recognized a single band in lysates of primary chondrocytes
from wild-type, but not mutant, mice (Figure 1C), and the signal
was undetectable by a nonspecific IgG (Figure 1B). To further
study neogenin expression, we took advantage of neogeninm/mDemutant mice that carry a LacZ knocked-in in the neogenin
gene, whose expression could be a reporter of endogenous neo-
genin expression (Mitchell et al., 2001). Indeed, LacZ activity,
detectable in both hetero (+/m) and homozygote (m/m),
exhibited a pattern similar to that revealed by immunostaining
(Figure 1D). Together, these results demonstrate neogenin
expression in developing chondrocytes and osteoblasts with
a highest level in hypertrophic chondrocytes.
Impaired Endochondrial Bone Formation
in Neogenin-Deficient Mice
To determine if neogenin regulates chondrogenesis in vivo, we
examined the structure of distal ulnas of newborn mutant mice.
The overall width of ulnas was reduced in mutant mice invelopmental Cell 19, 90–102, July 20, 2010 ª2010 Elsevier Inc. 91
Figure 2. Reduction of Chondrocyte Prolif-
eration and Apoptosis and Decrease of
Blood Vessel Invasion andOsteoblast Func-
tion in Neogenin-Deficient Growth Plates
(A and B) Decreased blood vessel invasion in
neogenin mutant mice, revealed by immunofluo-
rescence staining analysis of PECAM, a marker
for angiogenesis.
(C and D) Reduced bone matrix deposition in neo-
genin mutant mice, viewed by anti-collagen X
immunostaining.
(E and F) Decreased apoptosis at chondro-osseu
junction in neogenin mutant mice, revealed by
TUNEL analysis. The nuclei were stained with PI
(red). In (A)–(F), immunofluorescence staining or
TUNEL analyses were carried out in ulna sections
of newborn mice. Confocal images were shown in
(A), (C), and (E), and quantitative analyses of the
percentage of positive stained cells (over total
cells in the indicated area) were illustrated in (B),
(D), and (F). Data shown were mean ± SEM,
n = 3; **p < 0.01, significant difference from wild-
type control.
(G and H) Chondrocyte proliferation revealed by
immunohistochemical staining analysis of PCNA,
a marker for cell proliferation, in ulna sections of
P3 mice. DAB images were shown in (G), and
quantification analysis of the percentage of posi-
tive stained cells (over total cells in the indicated
proliferative zone) was shown in (H). Data shown
were mean ± SEM, n = 3; *p < 0.05, significant
difference from wild-type control. Bar, 120 mm.
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length of the growth plate, including prehypertrophic and hyper-
trophic zones, was increased inmutant mice (Figures 1E and 1F).
These results implicate deficient terminal differentiation of chon-
drocytes. In addition, endochondral bone ossification was
reduced in neogenin mutant growth plates (Figures 1E and
1G). Whereas there was no calcium deposition invading into
the hypertrophic zones (Figures 1E and 1G), the mineralization
capability of periochondral cells appeared to be unaffected
(Figure 1E). Defective chondrocyte maturation was also
observed in the growth plates of 2-3-week-old mutant mice
(data not shown). Taken together, these results suggest that
neogenin is required for terminal chondrogenesis and/or endo-
chondral bone formation in vivo.
Cartilage hypertrophy, blood vessel invasion, and osteoblast
invasion are coordinated and highly regulated during chondro-92 Developmental Cell 19, 90–102, July 20, 2010 ª2010 Elsevier Inc.genesis (Goldring et al., 2006). To deter-
mine if neogenin regulates these events,
we studied expression of PECAM, a
marker for invading blood vessels.
PECAM positive cells were distributed
at the cartilage/bone junction invading
into the hypertrophic zone of wild-type
mice (Figure 2A). However, they were
reduced in number and sparsely distrib-
uted at the end of hypertrophic zones in
mutant (Figure 2B), indicating defective
angiogenesis. Collagen X, a matrixprotein secreted by mature hypertrophic chondrocytes and
osteoblasts (Mackie et al., 2008), was reduced in mutant growth
plates (Figures 2C and 2D), suggesting defective osteoblast
invasion. Moreover, 10% of cells at the hypertrophic zone
were apoptotic in wild-type mice (Figures 2E and 2F), consistent
with previous reports (Yoon et al., 2005, 2006). However, the
number of apoptotic cells was reduced in mutant mice (Fig-
ures 2A and 2B). The chondrocyte cell proliferation was also
examined by immunohistochemical staining of proliferating
cell nuclear antigen (PCNA). The number of PCNA positive cells
and the length of the proliferative zone in neogenin mutant
appeared to be similar to that of wild-type control (Figure 2G).
However, the ratio of PCNA positive cells over total cells was
reduced in mutant growth plates (Figure 2H), suggesting that
neogenin mutant chondrocytes may also have reduced mitotic
activity.
Figure 3. Defective Chondrogenesis In Vitro in Cells from Neogenin-Deficient Mice
(A and B) Western blot (A) and immunostaining (B) analyses of neogenin expression in wild-type (+/+) andmutant (m/m) chondrocytes. Neogenin was detected in
wild-type, but not mutant, chondrocytes, demonstrating the specificity. Bar, 5 mm.
(C) Reduced in vitro chondrocyte differentiation in neogenin-deficient cells. Chondrocytes from newborn wild-type and mutant mice were incubated with differ-
entiation medium (DM, growth medium supplemented with 10 mM b-glycerophosphate and 50 mg/ml ascorbic acid) for indicated days. Cells were stained with
Alcian blue to view chondrocyte matrix, a differentiation marker. Bar, 50 mm.
(D–F) Real-time PCR analysis of genes associated with chondrocyte proliferation and/or differentiation (D), different transcriptional factors known to be important
for chondrocyte differentiation (E), and BMP downstream target genes (F) was shown. In (D)–(F), chondrocytes isolated from newborn mice were cultured in the
presence of growth medium (GM) or differentiation medium (DM) for 24 hr. RNAs were isolated for real-time PCR analysis as described in Experimental Proce-
dures. Date were normalized by internal control of GAPDH, and presented as fold over wild-type control (mean ± SD, n = 6); asterisks denotes p < 0.05, significant
difference from wild-type control.
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in a Cell-Autonomous Manner
We next examined if neogenin regulates terminal chondrogene-
sis in a cell autonomous manner. In vitro chondrogenesis assay
was performed using chondrocytes derived from wild-type and
neogenin mutant costal cartilages. Wild-type, but not mutant,
chondrocytes express neogenin (Figures 3A and 3B). In the pres-
ence of the differentiation medium (DM), wild-type chondrocytes
showed a time-dependent cartilage matrix deposition, revealed
by Alcian blue staining (Figure 3C). In contrast, cartilage matrix
deposition was reduced in neogeninm/m chondrocytes
(Figure 3C), suggesting a requirement of neogenin for chondro-
genesis in vitro and demonstrating a cell autonomous effect by
neogenin in this event.
To further study neogenin regulation of chondrocyte matura-
tion, we studied expression of genes associated with different
stages of chondrocyte proliferation and/or differentiation.
Expression of terminal differentiation markers, such as collagen
X (Col X) and osteocalcin, was reduced when mutant chondro-
cytes were cultured in DM, although MMP9 was slightly reduced
(Figure 3D). In contrast, collagen II (Col II), a protein associated
with proliferative chondrocytes, was increased in the mutantDeculture at both GM (growth medium) and DM (Figure 3D). These
results, in line with impaired endochondral bone formation in
neogenin mutant growth plates, further support for neogenin in
chondrocyte maturation.
To understand how neogenin regulates chondrocyte matura-
tion, we compared expression levels of transcription factors
essential for chondrogenesis, including Sox6, Sox9, and Runx2
(Karsenty, 2008; Karsenty and Wagner, 2002). Runx2, but not
Sox6/9, was down-regulated in neogenin mutant culture partic-
ularly at differentiation condition (Figure 3E). Runx2 is known to
be induced by the BMP pathway (Karsenty, 2008; Karsenty
and Wagner, 2002); therefore, we examined expression of other
BMP target genes, including Id1 and Atoh8 (Meynard et al.,
2009). Indeed, their expression was induced only in wild-type,
but not mutant, culture upon differentiation (Figure 3F), support-
ing the view for a defective BMP signaling in neogenin mutant
chondrocytes.
Requirement of Neogenin for BMP-Induced Smad
Phosphorylation, but Not p38 MAPK Activation
Next, we determined if neogenin is required for BMP signaling,
a pathway crucial for Runx2 expression and endochondralvelopmental Cell 19, 90–102, July 20, 2010 ª2010 Elsevier Inc. 93
Figure 4. Reduction of Smad1/5/8, but Not
p38MAPK, Phosphorylation and Decreased
Runx2 Expression in Neogenin-Deficient
Chondrocytes in Response to BMP2
(A) Decreased BMP2-induced p-Smad1/5/8,
but not p-p38 MAPK, in chondrocytes from
neogenin mutant mice. Chondrocytes from
neogenin+/+ and m/m mice were serum starved
for overnight and then stimulated with BMP2
(100 ng/ml) for the indicated time. Cell lysates
were analyzed by western blotting using indicated
antibodies.
(B and C) Quantitative analysis of data from (A).
Phosphorylation of Smad1/5/8 and p38 MAPK-
were normalized by total Smad1 and p38, respec-
tively, and quantified by Image J software. Data
shown were mean ± SD, n = 3; *p < 0.05, in
comparison with control.
(D and E) Normal TGF-b and FGF signaling in neo-
genin-deficient chondrocytes. Serum starved
chondrocytes were treated with 50 ng/ml TGF-
b (D) or 10 ng/ml FGF2 (E) for the indicated time.
(F) Reduction of BMP2-induced Runx2 expression
in neogenin mutant chondrocytes, which was re-
vealed by real-time PCR analysis. Chondrocytes
from the wild-type and mutant littermates were
treated with BMP2 (100 ng/ml) for 2 days. Runx2
transcripts were analyzed by real-time PCR and
normalized by internal control GAPDH. Data
shown were fold over wild-type control (mean ±
SD) from three independent experiments with
duplicate or triplicate samples each; *p < 0.05,
significant difference from the wild-type control.
(G) Rescue of defective BMP reporter expression
by neogenin. Wild-type and neogenin mutant
chondrocytes were transiently transfected vector
(control) or neogenin with BMP signaling reporter
plasmid (9XSBE-Luc). Transfected cells were
stimulated with BMP2 (100 ng/ml). Luciferase
activity was normalized and presented as
mean ± SD of triplicates from a representative
experiment. *p < 0.05, in comparison with the
absence of BMP stimulation.
(H) Decreased p-Smad1/5/8 in neogenin mutant growth plates. Cartilage lysates derived from wild-type (+/+) and neogenin mutant (m/m) mice at P1 were sub-
jected for western blot analysis using indicated antibodies.
(I) Illustration of a working model for neogenin regulation of BMP signaling and function.
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Neogenin Regulates Chondrogenesisbone formation (Yoon and Lyons, 2004). Chondrocytes were
treated with recombinant BMP2, which increased Smad1/5/8
phosphorylation (p-Smad1/5/8) in a time-dependent manner in
wild-type culture: elevated within 5 min, and remained high to
60 min (Figures 4A and 4B). However, in neogeninm/m chondro-
cytes, BMP2 induction of p-Smad1/5/8 was delayed and tran-
sient: not elevated until 15min, and returned to basal levelswithin
60 min of stimulation (Figures 4A and 4B), suggesting a require-
ment of neogenin for the induction and maintenance of p-
Smad1/5/8. Interestingly, neogenin was only required for BMP2
induction of Smad signaling, but not for noncanonical signaling
events, as BMP2-stimulated p38 MAPK phosphorylation was
similar in timecourse and intensity betweenwild-type andmutant
chondrocytes (Figures 4A and 4C). Moreover, it is specific for the
BMP pathway, not TGFb stimulated signaling, because phos-
phorylation of Smad2 and Erk in response to TGFb showed
no difference between wild-type and mutant chondrocytes94 Developmental Cell 19, 90–102, July 20, 2010 ª2010 Elsevier Inc.(Figure 4D). Furthermore, Stat1 and Erk activation by FGF,
another growth factor important for chondrogenesis, was similar
between wild-type and neogenin-deficient cells (Figure 4E).
Together, these observations demonstrate the specificity of neo-
genin in regulating BMP-induced canonical Smad signaling. In
support of this notion was the observation that Runx2 induction
byBMP2, revealed by real-timePCRanalysis, was only observed
in wild-type, but not mutant, chondrocytes (Figure 4F).
To determine if the defective BMP2 signaling in neogenin-defi-
cient cells can be rescued by expression of neogenin, mutant
chondrocytes were transiently transfected with neogenin with
or without 9XSBE-Luc, a luciferase reporter that contains 9
BMP-Smad responsive elements. Neogenin mutant cells ex-
hibited a reduction of the luciferase activity in response to
BMP2 (Figure 4G). Expression of neogenin indeed rescued the
phenotype, increasing reporter expression by BMP2 (Figure 4G).
These results suggest that the defective BMP2 induction of
Figure 5. In Vitro Rescue of Defective BMP Signaling and Function in Neogenin-Deficient Cells by High Doses of BMP2
(A and B) Decreased p-Smad1/5/8 was only observed in neogenin mutant chondrocytes in response to low, but not high, doses of BMP2. Chondrocytes from
neogenin+/+ and m/m mice were serum starved for overnight, then stimulated with indicated doses of BMP2 for 30 min. Data from (A) were quantified by Image J
software, normalized by total Smad1 and presented in (B) as fold over wild-type control (BMP2, 5 ng/ml; mean ± SD, n = 3).
(C–F) Defective in vitro chondrocyte differentiation in neogenin mutant cells was rescued by high dose of BMP2 (D), but not low dose of BMP2 (C) or netrin-1 (E).
Chondrocytes from new born wild-type and neogenin mutant mice were incubated with the differentiation medium without or with indicated doses of BMP2 or
netrin-1 for indicated days. Chondrocyte differentiation was revealed by Alcian blue staining. Images were shown in (C)–(E), and quantification analyses of data
from ([C–E], day 7) were illustrated in (F). OD620 values over the wild-type control were presented (mean ± SEM, n = 3). *p < 0.05, significant difference fromwild-
type. Bar, 50 mm.
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of neogenin protein.
We next addressed if neogenin regulates BMP signaling
in vivo. Smad1/5/8 phosphorylation was examined in ulnas carti-
lages of newborn wild-type and mutant mice. The p-Smad1/5/8
was reduced in mutant cartilage, especially in prehypertrophic
chondrocytes and trabecular osteoblasts, in comparison with
the wild-type control (Figure S2). Consistently, p-Smad1/5/8
levels were reduced in lysates of mutant tibia cartilage
(Figure 4H). In contrast, no apparent change was detected for
Smad1 protein, phosphorylation of p38 MAPK and Erk
(Figure 4H), pStat1 that was activated by FGF, or pSmad2 that
was activated by TGF-b (data not shown), demonstrating the
specificity of the effect of neogenin. Together with in vitro
studies, these in vivo results support the model that neogenin
is necessary for BMP-induced Smad1/5/8 signaling and subse-
quent expression of Runx2 (Figure 4I).DeRescue of Defective BMP Signaling and
Chondrogenesis in Neogenin-Deficient Chondrocytes
by High Dose of BMP2
We next addressed if the defective BMP signaling and function
in neogenin mutant chondrocytes can be rescued by exogenous
BMP2 treatment. Wild-type and mutant chondrocytes were
treated with BMP2 and induced Smad1/5/8 phosphorylation
and chondrocyte differentiation were examined. Cells treated
with 50–100 ng/ml BMP2 showed a decrease of p-Smad1/5/8
in neogeninm/m cells as compared with the wild-type control
(Figures 5A and 5B). However, BMP2 at doses of >500 ng/ml
induced comparable p-Smad1/5/8 in neogenin mutant cells
to that in the wild-type control (Figures 5A and 5B). In line
with this observation, high doses of BMP2 (1000 ng/ml) nearly
completely rescued chondrocyte differentiation phenotype as
revealed by Alcian blue-stained cartilage matrix deposition
(Figures 5C, 5D, and 5F). Treatment with netrin-1 at both highvelopmental Cell 19, 90–102, July 20, 2010 ª2010 Elsevier Inc. 95
Figure 6. Requirement of Neogenin for BMP-Induced BMP Receptor Association with Lipid Rafts
(A) Abolished lipid raft association of BMP receptors (Ia and II) in neogenin mutant chondrocytes in response to BMP2. Primary cultured chondrocytes were
treated with or without 100 ng/ml BMP2 for 60 min. Cell lysates were subjected to ultracentrifuge analysis and collected as 12 fractions. Each fraction was
analyzed by western blotting using indicated antibodies. Fraction 5 (between the red dot lines) was considered as lipid raft fraction, as flotinin, a marker of lipid
rafts, was enriched in this fraction.
(B–D) Data from (A) were quantified by Image J software and presented as percentage of raft fraction over total fractions (mean ± SEM, n = 3). *p < 0.01, in compar-
ison with control.
(E and F) Neogenin association with lipid raft fraction in wild-type chondrocytes stimulated with BMP2. Western blots were shown in (E) and quantification
analysis of data was illustrated in (F). Data shown were percentage of raft fraction over total fractions (mean ± SEM, n = 3). *p < 0.01, in comparison with
control.
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the phenotype (Figures 5E and 5F). These results provide
additional evidence for defective BMP signaling and function
in neogenin mutant cells and suggest that neogenin may play
a role in modulating BMP receptor sensitivity and/or binding
to BMPs.
Dependence on Neogenin for BMP2-Induced BMP
Receptor Association with Membrane Microdomains
To explore underlying mechanisms, we first determined if BMP
receptor level and distribution were altered in neogenin mutant
chondrocytes. Western blot and real-time PCR analyses demon-
strated a comparable level of BMP receptor (II) in neogenin-defi-
cient chondrocytes as wild-type control (Figures S3A and S3B).
Type IA (BMPRIA) appeared to be slightly reduced in the mutant96 Developmental Cell 19, 90–102, July 20, 2010 ª2010 Elsevier Inc.cells by western blot, but not by real-time PCR analysis (Figures
S3A and S3B). Similarly, immunostaining analysis showed
comparable levels of BMPRIA andBMPRII in both types of chon-
drocytes (Figure S3C). We next examined if BMP receptor asso-
ciation with membrane microdomains of lipid rafts, an event
important for BMP signaling (Hartung et al., 2006), is altered in
mutant chondrocytes. Chondrocytes were fractionated by Opti-
Prep density gradient centrifugation (Zhu et al., 2006). Twelve
fractions were isolated and fraction 5 was identified as a lipid
raft fraction, as it was associated with flotillin-1 and caveolin 1,
markers of lipid rafts (Figure 6A; Magee et al., 2002). Note that
BMP receptors (IA and II) were not detected in the raft fraction
(#5) in the absence of BMP stimulation (Figure 6A). However,
upon BMP stimulation, they became present in the lipid raft frac-
tion of wild-type chondrocytes (Figures 6A and 6C). Remarkably,
Figure 7. Requirement of Lipid Raft Associ-
ation of BMP Receptors for BMP Induction
of Smad1/5/8, but Not p38 MAPK, Phos-
phorylation and Chondrocyte Differentia-
tion
(A) Depletion of cholesterol by MCD treatment
suppressed phosphorylation of Smad1/5/8, not
p38. Primary cultured chondrocytes were pre-
treated with 5 mM MCD for 18 hr, followed by
BMP2 (100 ng/ml) stimulation for indicated time.
Cell lysates were collected and subjected for
western blotting analysis using anti-pSmad1/5/8
and p-p38 MAPK antibodies. Stripped mem-
branes were reblotted with antibodies against
Smad1, p38 MAPK, and b-actin to indicate equal
amount of loading.
(B and C) Quantitative analysis of results from (A).
Phosphorylation of Smad1/5/8 and p38 were
quantified by Image J software and normalized
by Smad1 and p38, respectively. Data shown
were mean ± SEM, n = 3, *p < 0.05, in comparison
with control. Bar, 50 mm.
(D) Chondrocyte differentiation was attenuated by
lipid raft disruption by MCD. Primary cultured
chondrocytes were cultured in chondrocyte differ-
entiationmedium together with or without MCD for
indicated times. Chondrocyte differentiation was
evaluated by Alcian blue staining.
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was abolished in neogenin mutant chondrocytes (Figures 6A
and 6C), suggesting a requirement of neogenin. This effect ap-
peared to be specific, as flotillin-1 level was unchanged in
mutant or wild-type chondrocytes in response to BMP2 stimula-
tion (Figures 6A and 6D). In supporting this view, neogenin asso-
ciation with the raft fraction was also observed upon BMP stim-
ulation, but not at the basal condition (Figures 6E and 6F).
Requirement of Membrane Microdomain Association
of BMP Receptors for BMP Induction of Smad
Phosphorylation and In Vitro Chondrogenesis
Next, we determined whether BMP receptor association with
lipid rafts may be required for BMP induction of canonical
Smad1/5/8 phosphorylation. Methyl-b-cyclodextrin (MCD) is
a water-soluble cyclic oligomer that is able sequester cholesterol
within its hydrophobic core. It has been widely accepted as
a plasma membrane cholesterol chelator to disperse lipid rafts
(Zhu et al., 2006; Zidovetzki and Levitan, 2007). Pretreatment
with 5 mMMCD for 8 hr abolished BMP2-induced BMP receptor
association with lipid rafts (data not shown) and reduced Smad1/
5/8 phosphorylation (Figures 7A and 7B). However, p38 MAPKDevelopmental Cell 19, 90phosphorylation by BMP2 was not
affected, and the basal level was in-
creased in the presence of MCD (Fig-
ures 7A and 7C). These results suggest
a requirement for lipid raft association of
BMP receptors in BMP induction of
Smad1/5/8 phosphorylation, but not
p38 MAPK activation. Moreover, we
found a significant reduction of cartilage
matrix deposition in MCD-treated differ-entiated chondrocytes (Figure 7D), indicating impaired in vitro
chondrogenesis.
RGM Expression in Chondrocytes that May Bridge
Neogenin with BMP Receptors for Membrane
Microdomain Association
To understand underlying mechanisms of neogenin regulation of
BMP receptor association with membrane microdomains, we
first examined if neogenin forms a complex with BMP receptors.
HEK293 cells expressing Myc-neogenin with or without HA-
BMPRs were subjected to coimmunoprecipitation. Weak or
undetectable level of neogenin was found in BMPRIA (ALK3) or
IB (ALK6) immunocomplexes (Figure 8A), suggesting little direct
interaction between neogenin and BMP receptors. We then
asked if RGM acts as a ‘‘bridging’’ protein for neogenin to asso-
ciate with BMP receptors, because RGMs not only interact with
neogenin but also bind to BMPs and BMPRs (Babitt et al., 2005,
2006; Rajagopalan et al., 2004; Samad et al., 2005; Zhang et al.,
2005). Coexpression of RGMc, indeed, increased neogenin
association with BMP receptors, particularly to BMPRIA (Fig-
ure 8A). These results suggest that a super BMP receptor
complex, including BMPR (IA), RGMc, and neogenin, can be–102, July 20, 2010 ª2010 Elsevier Inc. 97
Figure 8. RGM, a Linker of Neogenin with
BMP Receptors, in Lipid Rafts of Chondro-
cytes
(A) Coimmunoprecipitation analysis of neogenin
with BMP receptors in HEK293 cells. Lysates of
HEK293 cells expressing indicated proteins were
immunoprecipidated with anti-HA (for BMP recep-
tors) antibody. The resulting immunoprecipitates
were subjected for western blot analysis using
anti-Myc antibody (for neogenin). Loading lysates
expressing indicated proteins were revealed by
western blot analyses with indicated antibodies
(bottom panels).
(B) In situ hybridization analysis of RGMc expres-
sion in growth plates of P1 distal ulnas. Bar,
150 mm. High-magnification views of each layer
structures were shown in bottom panels. RGMc
was highly expressed in proliferative and hypertro-
phic chondrocytes and osteoblasts of the trabec-
ular bone. Bar, 10 mm.
(C) Western blot analysis of RGMa, b, and c
expression in chondrocytes from wild-type and
neogenin mutant mice.
(D) Coimmunoprecipitation analysis of neogenin
with BMPR1a and BMPR2 in chondrocytes. Chon-
drocytes were stimulated with or without BMP2
(100 ng/ml, 30 min). Cells were lysed with 1%
Triton X-100 containing buffer. Lysates were sub-
jected to the ultracentrifuge for isolation of DRM
(enriched in lipid rafts) fractions by sucrose
gradient as described in Supplemental Experi-
mental Procedures. The membrane proteins iso-
lated from DRM fractions were used for immuno-
precipitation and immunoblotting analyses with
indicated antibodies (see Supplemental Experi-
mental Procedures). Loading lysates were shown
on the bottom right panels, and spliced IP data
from the same SDS gel/blot were reshown in
bottom left panels.
(E) Reduced lipid raft association of RGMa and
RGMc in neogenin mutant chondrocytes stimu-
lated with BMP2. Chondrocytes from wild-type
(+/+) and neogenin mutant (m/m) mice were
treated with or without 100 ng/ml BMP2 for
60 min. Cell lysates were subjected for lipid raft isolation as described in Figure 6. The resulting 12 fractions were subjected to western blot analyses with indi-
cated antibodies.
(F) Data from (E) were quantified by Image J software and presented as percentage of raft fraction over total fractions (mean ± SEM, n = 3). *p < 0.05, in compar-
ison with wild-type control.
(G) A diagram illustrating the model for RGMs in bridging neogenin with BMP receptors at the lipid raft in response to BMP stimulation, where p-Smad1/5/8
is activated. In neogenin mutant chondrocytes, reduced RGMs and BMP receptors were found in the lipid raft. Thus, a reduced p-Smad1/5/8 signaling and
function was observed.
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with BMPRs.
We next determined if RGMc is expressed in chondrocytes
in vivo and in culture. In situ hybridization analysis
demonstrated that RGMc transcript was expressed in chondro-
cytes at P1 growth plates (Figure 8B), high in the proliferative
and pre- and hypertrophic zones (Figure 8B). It was also de-
tected in cultured chondrocytes by western blot analysis
(Figure 8C). In addition to RGMc, RGMa, and RGMb were
also expressed in chondrocytes (Figure 8C). Note that RGM
protein levels were unaffected in neogenin mutant chondro-
cytes (Figure 8C). We then examined if endogenous neogenin
forms a complex with BMPR1A, BMPR2, and RGMc in chon-98 Developmental Cell 19, 90–102, July 20, 2010 ª2010 Elsevier Inc.drocytes with or without BMP stimulation. To this end, DRM
(detergent-resistant membrane) fractions were used for coim-
munoprecipitation analysis. Neogenin was detected in immuno-
complexes of BMPRIA, BMPR2, or RGMc, which were
increased by BMP2 stimulation (Figure 8D). The increase of
neogenin association with BMPR1A, BMPR2, or RGMc was
specific, as neogenin was not detected in the immunocomplex
with a nonspecific (NS) rabbit serum nor caveolin-1 (Figure 8D).
Moreover, the increase of neogenin association with BMPR1A
or RGMc appeared to correlate well with their increase in lipid
rafts in response to BMP2 stimulation (Figure 8D). These results
support the view that BMP induces a super receptor complex in
membrane microdomains, which contains neogenin, RGMs,
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and RGMc were detected in the lipid raft fraction of lysates
from both wild-type and mutant chondrocytes (Figure 8E).
However, upon BMP stimulation, both RGMa and RGMc asso-
ciation with lipid raft fraction was increased in wild-type, but not
neogenin mutant, chondrocytes (Figures 8E and 8G), suggest-
ing a requirement of neogenin for BMP2-induced RGMs asso-
ciation with lipid rafts.
DISCUSSION
The present study provides evidence for neogenin in regulating
BMP-induced Smad1/5/8 phosphorylation, terminal chondro-
genesis, and endochondral bone formation. Our results suggest
that neogenin may regulate chondrocyte maturation by
promoting BMP-induced BMP receptor association with lipid
rafts, thus enhancing effective BMP receptor concentration or
BMP binding affinity and increaseing Smad phosphorylation
and Runx2 induction.
Neogenin was identified as a binding protein for axon guid-
ance cues like netrins and RGMs and has been implicated in
neural development (Rajagopalan et al., 2004; Wilson and Key,
2007; Yamashita et al., 2007; Zhang et al., 2005). This paper
provides evidence for a function of neogenin in endochondral
bone formation during skeleton development. This is supported
by the observations that neogenin is highly expressed in devel-
oping/differentiating chondrocytes in culture and in vivo; chon-
drocytes from neogenin-deficient mice show a reduction of
matrix deposition and defect on expression of genes associated
with chondrocyte maturation. In addition, neogenin mutant
mice are impaired in endochondral ossification, reduced chon-
drocyte hypertrophy, angiogenesis, and osteoblast invasion,
phenotypes associated with chondrocyte maturation or endo-
chondral bone formation.
Endochondral bone formation is essential for long bone
growth. It involves multiple cellular processes including mesen-
chymal condensation that form a template of chondrocytes, cell
proliferation and hypertrophy, and cell apoptosis, blood vessels
invasion, and bone matrix mineralization (Kronenberg, 2003).
Various extracellular factors including PTHrP, Ihh, Wnts, FGFs,
and BMPs coordinate to regulate different cellular processes
that eventually lead to endochondral bone formation (Kronen-
berg, 2003, 2006; Yoon and Lyons, 2004). Though how exactly
neogenin regulates endochondral bone formation remains to be
further investigated, our studies have pointed that neogenin acts
via regulating BMP signaling. This view is supported by the
observations that neogenin-deficient mice exhibit similar pheno-
types as loss-of-function BMPR1A (Bmpr1aCKO) and/or GDF5
mutants (Baur et al., 2000; Yi et al., 2000; Yoon et al., 2005,
2006). Both mutants show expanded pre- and hypertrophic
cartilage and defective hypertrophic terminal differentiation
(Yoon et al., 2006). In primary culture, neogenin-deficient chon-
drocytes show altered time course of Smad1/5/8 phosphoryla-
tion, reduced Runx2 gene induction, and decreased in vitro
chondrogenesis in response to BMP2, providing additional
support for neogenin regulation of BMP signaling and function.
In agreement with this view, recent reports suggest that
neogenin is required for BMP-induced hepcidin expression in
HepG2 cells (Zhang et al., 2009) and in mouse liver (Lee et al.,De2010). It is noteworthy that the skeleton phenotype in neogenin
mutant mice appeared to be ‘‘weaker’’ than those Bmpr1aCKO;
Bmpr1b+/, Bmpr1b/ or Smad1/5CKO;Smad8+/ triple knock-
out mutant mice (Retting et al., 2009; Yoon et al., 2006). Defec-
tive chondrocyte proliferation and reduced Sox9 expression
was observed in growth plates in Bmpr1aCKO;Bmpr1b+/ and
Smad1/5CKO;Smad8+/ mice (Retting et al., 2009; Yoon et al.,
2006), but not in neogenin mutant mice. This difference may
be due to neogenin selectively regulating BMPR1A signaling in
hypertrophic chondrocytes, as both neogenin and BMPR1A,
but not 1B, exhibit a similar expression pattern in growth
plates (prehypertrophic and hypertrophic zones) and forms
a protein complex in chondrocytes, and both neogenin/ and
Bmpr1aCKOmutants show similar phenotypes (elongated hyper-
throphic zones and defective hypertrophic differentiation) (Yoon
et al., 2006) (Figure 2). BMPR1B, however, is not expressed in
the same regions, but is expressed at higher level in proliferative
chondrocytes, and thus may have different function. Therefore,
the double mutant (Bmpr1aCKO;Bmpr1b+/) exhibit more sever
defects (Yoon et al., 2006). Similarly, Smad1/5/8 triple, but not
single, mutants show more severe phenotypes (Retting et al.,
2009; Yoon et al., 2006), in agreement with the notion that
only when all BMP signaling (1A and 1B) is disrupted, more
severe phenotypes occur. Taken together, these observations
suggest that Smad1/5/8 or BMP receptors (1A and 1B) have
broader functions than neogenin does and that neogenin specif-
ically regulates chondrocyte terminal differentiation, possible at
the level of BMPR1A.
Note that p38 MAPK phosphorylation induced by BMP
appears to be unaffected in neogenin mutant chondrocytes.
p38 MAPK is implicated in chondrogenesis, based on observa-
tions that inhibition of p38 activity affects cartilage nodule
formation (Oh et al., 2000) and influences the transition from
the prehypertrophic to hypertrophic chondrocyte phenotype
(Zhen et al., 2001). However, our results suggest that the defec-
tive chondrocyte maturation in neogenin mutant mice may be
primarily due to the impaired Smad, but not p38 MAPK,
signaling.
Our studies have suggested an intriguing mechanism under-
lying neogenin regulation of BMP-induced canonical Smad
signaling. Neogenin appears to promote BMP receptor associa-
tion with membrane microdomains (e.g., lipid rafts), where BMP
activates Smad1/5/8, but not p38 MAPK pathway. Lipid raft is
known to serve as a signaling platform on cell membrane where
multiple signal pathways are initiated (Lajoie et al., 2009). BMP
receptors have been found to be associated with lipid rafts in
a variety of cell types, including vascular smooth muscle cells
and pulmonary endothelium (Hartung et al., 2006; Wertz and
Bauer, 2008). Our studies have suggested a role of lipid raft in
BMP2-induced canonical Smad phosphorylation. This event
may be cell type dependent, as it has been reported that
BMP2 induces Smad1/5 phosphorylation in the nonlipid raft
regions in HEK293 cells (Hartung et al., 2006).
How does neogenin regulate BMP receptor association with
membrane microdomains /lipid rafts in response by BMP2?
Proteins that concentrated in lipid rafts include GPI-linked
proteins, doubly acylated proteins (e.g., Src-family kinases),
and cholesterol-linked and palmitoylated proteins. These
proteins may serve as anchors for harboring other proteinsvelopmental Cell 19, 90–102, July 20, 2010 ª2010 Elsevier Inc. 99
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BMP receptors heterodimerize and form a protein complex
with many other proteins, including RGMs, a family GPI
anchored proteins that acts as a BMP coreceptor (Babitt et al.,
2005, 2006; Samad et al., 2005) and neogenin. Neogenin may
facilitate and stabilize BMP receptor complex in the lipid rafts
by its interaction with RGMs. This view is supported by our
observations that RGMs are coexpressed with neogenin in
chondrocytes and associated with lipid raft fraction; expression
of RGMc increases neogenin association with BMP receptors
(e.g., BMPR1a); and that neogenin mutant cells reduced BMP2
stimulated RGMa and RGMc association with lipid rafts.
However, the exact role of RGMs during endochondral bone
formation remains to be further investigated.
In summary, our results suggest that neogenin plays an impor-
tant role in BMP receptor association with lipid raft, where BMP
induces canonical Smad1/5/8 phosphorylation, an essential
signaling for terminal chondrocyte differentiation and endochon-
dral bone formation. These results reveal an underlying
mechanism of neogenin regulation of BMP signaling, and impli-
cate neogenin as a potential convergent point for crossing talks
among different extracellular guidance cues (e.g., netrins and
RGMs) and growth factors (e.g., BMPs).
EXPERIMENTAL PROCEDURES
Animals
Neogenin mutant mice, kindly provided by Dr. Sue Ackerman (The Jackson
Laboratory), were generated by Bay Genomics as described previously
(Mitchell et al., 2001), which have been crossed into C57BL/6 genetic
background. Control littermates were processed in parallel for each exper-
iment. Neogenin mutation was confirmed by genotyping by PCR and by the
loss of the neogenin expression by western blot analysis. All experimental
procedures were approved by the Animal Subjects Committee at the
Medical College of Georgia, according to U.S. National Institute of Health
guidelines.
Skeletal Histology Analysis
Embryos and dissected limbs were skinned, eviscerated, and fixed in 95%
ethanol. Skeletal preparations were performed as described previously (Chen
et al., 2008). In brief, the embryos were stained in Alcian blue overnight at
room temperature. After rinsing with 95% ethanol, they were cleared in 1%
KOHovernight at 4Cand then stained in alizarin red overnight at room temper-
ature. The bone structures were cleared in gradient glycerol/KOH and stored in
100% glycerol. The samples were subject to photography and analysis.
Bone sections were stained with Alcian blue/von Kossa/nuclear fast red/
safranin O to show the histological structures. The sections were treated
with 3%acetic acid for 3min and stained in 1%Alcian blue for 30–45min. After
rinsed in tap water, the sections were stainedwith 2.5% silver nitrate for 30min
under UV light. Washed the slides and counterstained with nuclear fast red
for 3 min.
Primary Chondrocyte Culture and Differentiation
Primary chondrocyte culture was carried out as previously described (Mak
et al., 2008). In brief, ventral parts of the rib cages of 0- to 3-day-old wild-
type pups were eviscerated of skin and muscles and incubated with
2 mg/ml proteinase (Roche) for 30 min at 37C. The samples were then incu-
bated with 3mg/ml collagenase D (Roche) in DMEM (GIBCO) at 37C for 1.5 hr
until all soft tissues had detached from the cartilage. The cartilage was washed
with PBS several times and separated from soft tissues by sedimentation. The
cartilage was then digested with collagenase for 4–5 hr. Chondrocytes were
collected by centrifugation and plated on culture dishes at a density of
1 3 107 cells/ml. Cells were maintained in growth medium (GM; DMEM with
10% FBS plus penicillin and streptomycin). To induce chondrocyte differenti-100 Developmental Cell 19, 90–102, July 20, 2010 ª2010 Elsevier Incation, differentiation medium (DM; growth medium supplemented with 10 mM
b-glycerophosphate and 10 mg/ml ascorbic acid) were used. In some experi-
ments, recombinant BMP2 or netrin-1 were added into the DM as indicated.
To evaluate chondrocyte differentiation, Alcian blue staining was utilized.
Cultured chondrocytes were fixed in 80% methanol for 20 min at 20C and
then incubated with 0.1% HCl-Alcian blue for 2 hr. Excess stain was washed
off. Nodule number was counted. The stain was quantified by solubolizing
the stain with 6Mguanidine hydrochloride for 8 hr at room temperature. Absor-
bance of OD620 nm was measured using a spectrophotometer.
Isolation of Lipid Rafts
Lipid rafts were prepared as described previously (Zhu et al., 2006). In brief,
cells from a 100 mm dish, either control or treated, were washed two times
with ice-cold PBS and lysed with 1.3 ml of ice-cold TNE/CHAPS buffer
(20 mM CHAPS, 25 mM TRIS/HCl [pH 7.4], 150 mM NaCl, 3 mM EDTA,
13 PMSF, 13 Protease Inhibitor Cocktail [Sigma]). Lysates were rotated for
30 min at 4C and homogenized by passing through a 27 gauge needle
20 times. The homogenized lysates an OptiPrep concentration of 40% was
adjusted by adding 2.7 ml 60% OptiPrep solution. The mixture was vortexed
vigorously, transferred to an 12.5 ml ultracentrifuge tube (Beckman) and a dis-
continous OptiPrep gradient (30%, 5%) was formed above the lysate by add-
ing 4 ml 30%OptiPrep and subsequently 4 ml 5% OptiPrep. The gradient was
ultracentrifuged for 20 hr at 39,000 rpm and 4C using the SW40Ti rotor (Beck-
man Instruments, Fullerton, CA). Twelve fractions (1 ml each) were collected
from top to bottom and designated as fractions 1–12. Fractions were analyzed
using SDS-PAGE and subsequent western blotting. To verify the separation,
a specific caveolin 1 and flotinin 1 antibody was applied. The fractions 4 and
5 containing flotinin-1 were designated the lipid raft fractions. As a control,
100 ml of the lysate was transferred to an eppendorf-tube and centrifuged
for 20 min at 13,000 rpm and 4C. In some cases, lysates were concentrated
by acetone precipitation. The cleared control-lysates were denatured by add-
ing 20 ml 63 SDS-sample buffer and boiled for 5 min.
DRM Isolation, Immunoblotting, and Coimmunoprecipitation
Analysis
The immunoblotting analysis was carried out as described previously
(Ren et al., 2004).The cells were washed with ice-cold PBS and solubilized
for 30 min on ice in modified radioimmunoprecipitation assay (RIPA) buffer
or extraction buffer (0.5% Lubrol-PX, 50 mM KCl, 2 mM CaCl2, 4 mM
MgCl2, 20% glycerol, 50 mM Tris-HCl [pH 7.4]), supplemented with the
protease inhibitors. Lysates were centrifuged at 14,000 rpm for 10 min, and
the supernatants were used for immunoprecipitation or western blotting.
For coimmunoprecipitation, in addition to cell lysates, DRM (detergent resis-
tant membranes) fractions were used. DRM fractions were isolated as previ-
ously described (Okamoto et al., 2001). In brief, cells were lysed in TNE buffer
(25 mM Tris-HCl [pH 7.4], 150 mM NaCl, 5 mM EDTA, 13 PMSF, 13 protease
inhibitor cocktail) containing 1% Triton X-100. The DRMs were isolated by
gradient sucrose separation by ultracentrifuge (20 hr at 39,000 rpm, 4C).
The floating DRM bands were collected and diluted to 12 ml with TNE.
Membrane proteins were harvested by centrifugation for 1 hr at 120,000 3g.
The resulting pellets were resolubolized by RIPA buffer. The supernatants, pre-
cleared with protein A/G beads, were incubated with indicated antibodies and
protein A/G beads at 4C for overnight. After centrifugation, beads were
washed three times with TNE buffer. Bound proteins were eluted with SDS
sample buffer and subjected to SDS-PAGE and immunoblot analysis. For
quantitative analysis, autoradiographic films were scanned and analyzed
with NIH Image J software.
Statistical Analysis
Data were analyzed using an unpaired two tailed Student’s t test and are ex-
pressed as themean ± SD. p values less than 0.05 were considered significant.
Other Procedures
Materials and reagents, expression plasmids, X-Gal staining, transfection and
luciferase assays, immunofluorescence confocal microscopy, and quantita-
tive real-time RT-PCR analysis were described in Supplemental Experimental
Procedures..
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